title: Resolution of severe digital ulceration during a course of Bosentan therapy.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Snyder
authors.forename: Mary R
authors.initials: MR
authors.lastname: Jacobs
authors.forename: Rafael G
authors.initials: RG
authors.lastname: Grau
authors.forename: David S
authors.initials: DS
authors.lastname: Wilkes
authors.forename: Kenneth S
authors.initials: KS
authors.lastname: Knox
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D000077300:Bosentan; D065128:Endothelin Receptor Antagonists; D005385:Fingers / Q000098:blood supply*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D012595:Scleroderma, Systemic / Q000150:complications; D012883:Skin Ulcer / Q000188:drug therapy*; D013449:Sulfonamides / Q000627:therapeutic use*
chemical_list: D000959:Antihypertensive Agents; D065128:Endothelin Receptor Antagonists; D013449:Sulfonamides; D000077300:Bosentan